Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma-Reference-Cited by-同舟云学术

Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma

Published:2012-05-10 Issue:19 Volume:366 Page:1759-1769
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Palumbo Antonio,Hajek Roman,Delforge Michel,Kropff Martin,Petrucci Maria Teresa,Catalano John,Gisslinger Heinz,Wiktor-Jędrzejczak Wiesław,Zodelava Mamia,Weisel Katja,Cascavilla Nicola,Iosava Genadi,Cavo Michele,Kloczko Janusz,Bladé Joan,Beksac Meral,Spicka Ivan,Plesner Torben,Radke Joergen,Langer Christian,Yehuda Dina Ben,Corso Alessandro,Herbein Lindsay,Yu Zhinuan,Mei Jay,Jacques Christian,Dimopoulos Meletios A.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1112704

Cited by 656 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MM Therapy in Resource-Constrained Including Maintenance;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs;Clinical and Experimental Medicine;2024-08-06

3. Design and Synthesis of Some Novel 1-chloro-6-(4-(sulfonyl) piperidin-4-yl) phenyl)-6,7-dihydro-5H-cyclopenta[c]pyridin-5-ones as In Vitro Anticancer Agents;Indian Journal of Chemistry;2024-07-19

4. Psychoneuroimmunology in multiple myeloma and autologous hematopoietic stem cell transplant: Opportunities for research among patients and caregivers;Brain, Behavior, and Immunity;2024-07

5. Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program;Clinical Lymphoma Myeloma and Leukemia;2024-07